A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

December 31, 2009

Conditions
Atopic Dermatitis
Interventions
DRUG

S-777469 400 mg

S-777469 400 mg BID

DRUG

S-777469 800 mg

S-777469 800 mg BID

DRUG

Placebo

Placebo BID

Trial Locations (33)

11790

Stony Brook

19104

Philadelphia

23507

Norfolk

24501

Lynchburg

30022

Alpharetta

33134

Coral Gables

33401

West Palm Beach

37072

Goodlettsville

37934

Knoxville

46617

South Bend

47713

Evansville

55432

Fridley

60005

Arlington Heights

68144

Omaha

71913

Hot Springs

75230

Dallas

77058

Houston

77845

College Station

78229

San Antonio

78759

Austin

80210

Denver

83704

Boise

84088

West Jordan

90045

Los Angeles

92056

Oceanside

92506

Riverside

97035

Lake Oswego

97210

Portland

97223

Portland

973239

Portland

08009

Berlin

07652

Paramus

02919

Johnston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shionogi

INDUSTRY